Csquare, Inc.
CSQR
Sync financial data to generate a health grade for this company.
Analytical Summary
Review the statement evidence below to form a view on CSQR.
6-Year Financial Trajectory
QuarterlyStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) |
14.5%
Good
Good
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+21%)
|
— | — | — | — | — |
| EPS Growth YoY (%) |
-261.5%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — |
| Net Income Growth YoY (%) |
-88.9%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Operating Margin (%) (%) |
21.1%
Good
Good
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+6%)
|
— | — |
13.7%
Fair
Fair
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-32%)
|
— | — |
| Effective Tax Rate (%) (%) |
-33.4%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — |
13.6%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — |
| Profit Margin (%) (%) |
-23.5%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-257%)
|
— | — |
-14.3%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-195%)
|
— | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
1.8%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
4.0%
Caution
Caution
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
1.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — |
| Return on Common Equity (%) (%) |
17.0%
Good
Good
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-8%)
|
— | — |
-4.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-126%)
|
— | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Debt to Equity (x) |
-12.58x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-2896%)
|
— |
-37.52x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-8438%)
|
— | — | — |
| Interest Coverage (x) |
0.64x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
0.65x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
| Net Debt (USD) | $4.77B | — | $4.62B | $-32.30M | — | — |
| Debt / EBITDA (x) |
36.86x
Weak
Weak
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — | — | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Working Capital (USD) | $220.07M | — | $402.68M | — | — | — |
| LT Debt (USD) | $4.89B | — | $4.76B | — | — | — |
| Total Equity (USD) | $-388.62M | $-204.01M | $-126.75M | $721.75M | $734.88M | $778.42M |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $280.35M | — | — | $244.75M | — | — |
| Depreciation Expense (USD) | $73.50M | — | — | $50.40M | — | — |
| Net Income, GAAP (USD) | $-65.95M | — | — | $-34.91M | — | — |
Secondary lens
Benchmark Lens
Compare CSQR against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CSQR against peers after checking the statement evidence.
Compare CSQR with peers
Stack CSQR against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 2 days ago